Stephen P Robinson^1*, Anna Sureda^2*, Carmen Canals Sr.^3*, Jean-Paul Vernant^4*, Noel-Jean Milpied, PhD⁵, Jürgen Finke⁶, Johan Maertens^7*, Jean-Pierre Jouet, MD⁸, Charles F. Craddock, BM, MRCP, MRCPath⁹, Karl S Peggs, MD^10*, Steven Le Gouill, MD^11* and Norbert Schmitz, MD, PhD¹²

¹BMT Unit, University Hospital Bristol, Bristol, United Kingdom
²Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
³Lymphoma Working Party, EBMT, Barcelona, Spain
⁴Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, Paris, France
⁵Hopital Haut Leveque - Pessac, Pessac, France
⁶Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany
⁷Clinical Hematology Division, Hospital de Sant Pau, Barcelona, Spain
⁸Maladies du Sang, Rue Michel Polonovski, Lille, France
⁹Center for Clinical Hematology, Birmingham, ARRAY(0xc83fd08)
¹⁰Haematology, University College London, London, United Kingdom
¹¹Haematology, CHU Nantes, Nantes, France
¹²Hematology and Stem Cell Transplantation, ASKLEPIOS Klinik St. Georg, Hamburg, Germany

Stephen P Robinson^1*, Carmen Canals^2*, Didier Blaise, MD³, Kirsty Thomson^4*, Robert Foa⁵, Arturo Iriondo Atienza^6*, Jean-Luc Harousseau⁷, Catherine Cordonnier, MD⁸, Gordon Cook, MD, PhD^9*, Jean-Pierre Jouet, MD¹⁰, Jean-Yves Cahn, MD, PhD¹¹, Charles Crawley¹², Michel Attal, MD¹³, Marek Trneny, Assoc., Prof., MD, PhD¹⁴, H. Tilly^15* and Anna Sureda, MD^16*

¹BMT Unit, University Hospital Bristol, Bristol, United Kingdom
²Lymphoma Working Party, EBMT, Barcelona, Spain
³Institut Paoli Calmettes, Marseille, France
⁴Dept. Haematology, University College London, Hertfordshire, United Kingdom
⁵Dept. of Cellular Biotechnologies & Hematology, University 'Sapienza', Rome, Italy
⁶Hospital U. Marques de Valdecilla, Santander, Spain
⁷Hôpital Hôtel Dieu, Nantes, France
⁸Hematologie Clinique, Hopital Henri Mondor, Creteil, France
⁹BMT Office, St. James' University Hospital, Leeds, ARRAY(0xc0f75c4)
¹⁰Maladies du Sang, Rue Michel Polonovski, Lille, France
¹¹Hematology Department, CHU de Grenoble, Grenoble, France
¹²Clinical Hematology Division, Hospital Sant Pau, Barcelona, Spain
¹³Hopital Purpan, Toulouse, France
¹⁴First Dept. of Medicine, Charles Univ. General Hosp., Prague, Czech Republic
¹⁵Centre Henri Becquerel, Rouen, France
¹⁶Hematology, Hospital Sant Pau, Barcelona

Cesar O Freytes, MD¹, Jeanette Carreras, MPH^2*, Mei-Jie Zhang, PhD^2*, Ginna G. Laport, MD³, Koen Van Besien, MD⁴, Hillard M. Lazarus, MD⁵ and Parameswaran Hari, MD, MS^2*

¹University of Texas Health Science Center, San Antonio, TX
²Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research, Milwaukee, WI
³Stanford University Medical Center, Stanford, CA
⁴University of Chicago, Chicago, IL
⁵University Hospitals Case Medical Center, Cleveland, OH

Barbara Sarina, MD^1*, Luca Castagna, MD^1*, Fabio Benedetti, MD^2*, Francesca Patriarca, MD^3*, Michele Malagola, MD^4*, Silvia Ferrari, MD^5*, Roberto Sorasio, MD^6*, Lucia Farina, MD^7*, Enrico Morello, MD^8*, Alessandro Bonini, MD^9*, Nicola Mordini, MD^10*, Sergio Tamiazzo, MD^11*, Michele Falda, MD^12*, Laura Giordano, PhD^1* and Paolo Corradini, MD⁷

¹Hematology-Oncology, IRCCS Istituto Clinico Humanitas, Rozzano, Italy
²Hematology, University of Verona, Verona, Italy
³Hematology, University of Udine, Italy
⁴Chair of Hematology, University of Brescia, Brescia, Italy
⁵Hematology, Spedali Civili, Brescia
⁶Hematology, University of Torino
⁷Hematology - BMT, Istituto Tumori, University of Milano, Milano, Italy
⁸Hematology, Ospedale Bolzano
⁹Reggio Emilia Hospital
¹⁰Hematology, Ospedale S Croce Cuneo
¹¹Hematology, Ospedale SS Antonio e Biagio, Alessandria, Italy
¹²Ospedale Maggiore San Giovanni Battista, Torino, Italy

Henk Lokhorst, MD, PhD^1*, Pieter Sonneveld, MD, PhD^2*, Bronno van der Holt, PhD^3*, Marinus van Oers, MD, PhD^4*, Reinier Raymakers, MD, PhD^5*, Sonja Zweegman, MD, PhD⁶, Monique C. Minnema, MD, PhD⁷ and Mark Zijlmans, MD, PhD^3*

¹Hematology, University Medical Center Utrecht, Utrecht, Netherlands
²Hematology, Erasmus Medical Center Rotterdam
³Erasmus MC - Daniel den Hoed Cancer Center, Rotterdam, Netherlands
⁴Amsterdam Medisch Centrum
⁵University Medical Center Nijmegen
⁶Dept. of Hematology, 2pk BR018, VUMC, Amsterdam, Netherlands
⁷Hematology B.02218, UMC Utrecht, Utrecht, Netherlands

Shuichi Mizuta¹, Masamitsu Yanada^2*, Isamu Sugiura³, Fumiharu Yagasaki^4*, Toshiaki Yujiri⁵, Makoto Takeuchi^6*, Yoshihiro Hatta⁷, Yukihiko Kimura^8*, Yasunori Ueda, MD⁹, Heiwa Kanamori^10*, Noriko Usui¹¹, Hideki Akiyama¹², Yasushi Miyazaki, MD, PhD¹³, Shigeki Ohtake¹⁴, Itsuro Jinnai, MD⁴, Keitaro Matsuo^15*, Tomoki Naoe, MD² and Ryuzo Ohno, MD^16*

¹Dept. of Hematology, Fujita Health University, Toyoake, Japan
²Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
³Toyohashi Municipal Hospital, Toyohashi, Japan
⁴Department of Hematology, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan
⁵Yamaguchi University School of Medicine, Yamaguchi, Japan
⁶National Hospital Organization Minami-Okayama Medical Center, Okayama, Japan
⁷Hematology & Rheumatology, Nihon University, Tokyo, Japan
⁸Tokyo Medical College, Japan
⁹Kurashiki Central Hospital, Kurashiki, Japan
¹⁰Kanagawa Cancer Center, Yokohama, Japan
¹¹Jikei University School of Medicine, Tokyo, Japan
¹²Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
¹³Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasakishi, Japan
¹⁴Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
¹⁵Division of Epidemiology and Prevention, Aichi Cancer Center, Nagoya, Japan
¹⁶Japan Adult Leukemia Study Group, Japan